DEFINITIVE CONTRACT
Active75F40126C00080
Department of Health and Human Services › Food and Drug Administration › FDA OFFICE OF ACQ GRANT SVCS
$884.9K
obligated · signed 2 months ago
FY26C1AP30 - NAM-ALIGNED PEDIATRIC GLIOBLASTOMA
Performance timeline
Start
Sep 1, 2026
End
Aug 31, 2029
with all options
Loading status
Estimated start: Aug 31, 2028
AMERICAN TYPE CULTURE COLLECTION
Contract 75F40126C00080
UEI
KT4MLLHK99V6
Parent Company
AMERICAN TYPE CULTURE COLLECTION
Capabilities & Certifications
Headquarters Location
Congressional District: 10
Current Obligation
$884,879
Base + Exercised Options
$884,879
Total Ceiling Value
$1,742,521
Contract Type
FIRM FIXED PRICE
Multi-Year Contract
NO
NAICS
RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)
PSC
HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH
Place of Performance
Congressional District: 10
Awarding Agency
Top-tier agency
Food and Drug Administration
Sub-tier agency
FDA OFFICE OF ACQ GRANT SVCS
Office
Funding Agency
Top-tier agency
Food and Drug Administration
Sub-tier agency
FDA OFFICE OF ACQ GRANT SVCS
Office
Solicitation procedures, competition exceptions, labor standards and account totals.